Giotto Technologies has completed the acquisition of Maxima’s intellectual property assets, including patents, technical drawings, industrial know-how, and the Maxima brand. This strategic move broadens Giotto’s technological capabilities and expands its portfolio of tissue converting solutions.
The acquisition complements Giotto’s existing range of converting lines, which serve both consumer and professional away-from-home (AFH) markets. Giotto’s current platforms include SmartRoll for consumer products, Genium for high-end consumer and industrial applications, and SmartFlex for AFH products. These platforms support production speeds of up to 700 meters per minute across the product range.
Following the acquisition, Giotto Technologies plans to progressively integrate Maxima’s technological assets into its manufacturing and engineering operations. This integration is designed to maintain production continuity and provide long-term support for Maxima’s existing customers and installed converting lines worldwide.
Giovanni Bertoli Barsotti, CEO of Giotto Technologies, stated, “Our goal is to combine Maxima’s proven technologies and reliability with Giotto’s innovative DNA. This will enable us to develop new solutions, enhance existing converting lines and deliver increasingly competitive technologies to our customers.”
The company views this transaction as a significant step in its ongoing technological and industrial development. It aims to support sustainable growth and reinforce Giotto’s role as a key player in the global tissue converting industry.
The acquisition reflects Giotto’s commitment to innovation and customer service by integrating complementary technologies and expertise. By expanding its intellectual property portfolio, Giotto is positioned to offer enhanced converting solutions tailored to evolving market demands.
This development is expected to benefit both consumer and professional sectors by providing advanced converting lines with improved performance and reliability.
Giotto Technologies continues to invest in research and development to maintain its competitive edge and meet the needs of tissue product manufacturers worldwide.
The integration of Maxima’s assets will be managed carefully to ensure seamless operational transition and uphold the quality standards associated with both brands.
Giotto’s expanded portfolio now offers a comprehensive suite of converting technologies, reinforcing its capacity to serve diverse market segments efficiently.
The acquisition underscores the importance of intellectual property in driving innovation and sustaining growth within the tissue converting industry.
As Giotto Technologies advances this integration, it anticipates delivering enhanced value to customers through improved product offerings and technological advancements.
This transaction marks a pivotal moment in Giotto’s strategic development, positioning the company for continued leadership in the global tissue converting market.
Giotto Technologies Expands Tissue Converting Portfolio with Acquisition of Maxima’s IP and Technology Giotto Technologies has acquired Maxima’s patents, technical drawings, industrial know-how, and brand, enhancing its technological capabilities and product offerings in the tissue converting industry. The integration ai... Read the full IIPLA article: https://iipla.org/news/giotto-technologies-expands-tissue-converting-portfolio-with-acquisition-of-maxima-s-ip-and-technology